Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEPIGOID Phleum for Local Allergic Rhinitis
NCT02126111Phase 2Completed
- Start
- Oct 2010
- Primary completion
- Apr 2016
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in allergic rhinitis (AR) comparing DEPIGOID phleum with DEPIGOID Placebo & DEPIGOID Phleum (2 arms). Primary endpoint: Symptoms and medication scores comparison between active and placebo group at 2 years. Started Oct 2010; status: completed.
02
Drugs
depigoid phleum
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT02126111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02126111.